Toronto Dominion Bank
EBS icon

Toronto Dominion Bank’s Emergent Biosolutions EBS Stock Holding History

Toronto Dominion Bank’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-36,632
Closed -$432K – 1502
2022
Q4 		$432K Hold
36,632
– – ﹤0.01% 1157
2022
Q3 		$769K Buy
+36,632
New +$1.02M ﹤0.01% 1136
2020
Q1 		– Sell
-3,400
Closed -$183K – 1287
2019
Q4 		$183K Buy
+3,400
New +$184K ﹤0.01% 1021

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Toronto Dominion Bank's EBS Position: Q1 2023 in Review

Toronto Dominion Bank sold out of Emergent Biosolutions (EBS) in Q1 2023, closing a stake of 36,632 shares — an estimated $432K sold.

Toronto Dominion Bank first reported a position in EBS in Q4 2019 and held it in 3 quarters. The position peaked at $769K in Q3 2022. 191 funds tracked by Wall St. Rank hold EBS as of Q1 2023.

  • Toronto Dominion Bank reported no remaining Emergent Biosolutions position as of Q1 2023 after selling out during the quarter.
  • Toronto Dominion Bank sold 36,632 Emergent Biosolutions shares in Q1 2023, an estimated $432K.
  • Toronto Dominion Bank first reported a position in Emergent Biosolutions in Q4 2019 and held it in 3 quarters.
  • Toronto Dominion Bank's Emergent Biosolutions position peaked at $769K in Q3 2022.
  • 191 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2023.

Based on Toronto Dominion Bank's 13F filing for Q1 2023, filed 11 May 2023.